文献

J-GLOBAL ID：202002266649307580   整理番号：20A2808717

血液疾患患者での左室心筋緻密化障害の高罹患率と化学療法関連心機能障害に対する影響

High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases

著者 (28件)： Hirano Mitsuhito (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Kimura Koichi (Department of Laboratory Medicine, The Institute of Medical Science, The University of Tokyo) ,  Kimura Koichi (Department of General Medicine, The Institute of Medical Science, The University of Tokyo) ,  Kimura Koichi (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Ishigaki Tomohiro (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Ishigaki Tomohiro (Department of Laboratory Medicine, The Institute of Medical Science, The University of Tokyo) ,  Nojima Masanori (Center for Translational Research, The Institute of Medical Science, The University of Tokyo) ,  Daimon Masao (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Daimon Masao (Department of Laboratory Medicine, The University of Tokyo Hospital, The University of Tokyo) ,  Morita Hiroyuki (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Takenaka Katsu (Department of Laboratory Medicine, The University of Tokyo Hospital, The University of Tokyo) ,  Xu Boqing (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Sawada Naoko (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Hirokawa Megumi (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Komuro Issei (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) ,  Morisaki Takayuki (Department of General Medicine, The Institute of Medical Science, The University of Tokyo) ,  Yotsuyanagi Hiroshi (Department of General Medicine, The Institute of Medical Science, The University of Tokyo) ,  Kawamata Toyotaka (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Yokoyama Kazuaki (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Konuma Takaaki (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Kato Seiko (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Yasui Hiroshi (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Nagamura-Inoue Tokiko (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Nagamura-Inoue Tokiko (Department of Laboratory Medicine, The Institute of Medical Science, The University of Tokyo) ,  Uchimaru Kaoru (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Takahashi Satoshi (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Imai Yoichi (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo) ,  Tojo Arinobu (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo)
資料名： Circulation Journal  (Circulation Journal)
巻： 84  号： 11  ページ： 1957-1964(J-STAGE)  発行年： 2020年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:化学療法の最近の進歩により血液疾患患者の生存率が上昇し...

シソーラス用語： ヒト ,...
準シソーラス用語： *左室心筋緻密化障害 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2808717&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者キーワード (5件)： 心毒性 ,  心血管疾患危険因子 ,  心血管転帰 ,  左室非圧縮 ,  腫瘍学

分類 (3件)： 循環系の疾患  (GJ03000C) ,  血液の疾患  (GK03000F) ,  抗腫よう薬の臨床への応用  (GW16020L)

引用文献 (41件)：

• 1. Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2768-2801.
• 2. Okwuosa TM, Prabhu N, Patel H, Kuzel T, Venugopal P, Williams KA, et al. The cardiologist and the cancer patient challenges to cardio-oncology (or onco-cardiology) and call to action. J Am Coll Cardiol 2018; 72: 228-232.
• 3. Jain D, Russell RR, Schwartz RG, Panjrath GS, Aronow W. Cardiac complications of cancer therapy: Pathophysiology, identification, prevention, treatment, and future directions. Curr Cardiol Rep 2017; 19: 36.
• 4. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 2003; 97: 2869-2879.
• 5. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.

タイトルに関連する用語 (6件)： 血液 ,  疾患患者 ,  左室心筋緻密化障害 ,  罹患率 ,  化学療法 ,  心機能障害